39
Same as last weekARWR
Valuation50/ 100
Cash flow & growth54/ 100
Upside potential35/ 100
Risk potential63/ 100
ARWR's valuation appears fair, fundamentals are somewhat mixed and weaker than expected earnings are holding it back, though analyst coverage is limited and estimates vary widely.
ARWR vs Historical averages
| Metric | Current | Average | Relative |
|---|---|---|---|
| EPS | -$2.24 | -$1.80 | $0.44 lower |
| FCF | -$75.1M | -$151.1M | +$75.9M |
| Loading historical comparisons… | |||
ARWR’s earnings are below their historical averages.
ARWR Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | -- |
| Forward earnings | Loss widening |
| Forward revenue | Strong decline |
| Forward profitability | Strongly contracting |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
ARWR’s outlook is weakening, with weaker expected earnings weighing on the picture.
ARWR PE Valuation
Loading pe valuation table…
This table applies ARWR's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
ARWR Earnings Per Share
Loading earnings per share…
This chart tracks ARWR's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
ARWR Quarterly Revenue
Loading quarterly revenue…
This chart tracks ARWR's quarterly revenue over time and shows how sales are changing from year to year.
ARWR Free Cash Flow
Loading free cash flow…
This chart tracks ARWR's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
ARWR Total Shares
This chart tracks changes in ARWR's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
ARWR Net Leverage
Loading net leverage…
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
ARWR PE vs Healthcare Sector
Loading pe vs sector average…
This chart compares ARWR's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
ARWR Weekly Price
Loading weekly price…
This chart uses ARWR's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
ARWR Weekly Moving Averages
Loading weekly moving averages…
This chart compares ARWR's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
ARWR Yearly ROI
Loading yearly ROI…
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
NVO
55
Valuation50/ 100
Cash flow & growth55/ 100
Upside potential38/ 100
Risk potential39/ 100
NVO's valuation appears fair, fundamentals are somewhat mixed and expected margin pressure limits the outlook, though analyst coverage is limited.
NVO vs Historical averages
| Metric | Current | Average | Relative |
|---|---|---|---|
| PE | 11x | 28x | 62% lower |
| PE percentile | 5.4 | 50 | 89% lower |
| EPS | $4.09 | $2.36 | 74% higher |
| FCF | $7.6B | $8.5B | 10% lower |
| Loading historical comparisons… | |||
NVO’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly improving |
| Forward earnings | Strong growth |
| Forward revenue | Decline |
| Forward profitability | Strongly contracting |
| Analyst coverage | Limited |
| Estimate dispersion | Moderate |
NVO’s outlook is mixed, with declining sales expectations a concern.
NVO PE Valuation
Loading pe valuation table…
This table applies NVO's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
NVO Earnings Per Share
Loading earnings per share…
This chart tracks NVO's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
NVO Quarterly Revenue
Loading quarterly revenue…
This chart tracks NVO's quarterly revenue over time and shows how sales are changing from year to year.
NVO Free Cash Flow
Loading free cash flow…
This chart tracks NVO's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
NVO Total Shares
This chart tracks changes in NVO's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
NVO Net Leverage
Loading net leverage…
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
NVO PE vs Healthcare Sector
Loading pe vs sector average…
This chart compares NVO's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
NVO Weekly Price
Loading weekly price…
This chart uses NVO's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
NVO Weekly Moving Averages
Loading weekly moving averages…
This chart compares NVO's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
NVO Yearly ROI
Loading yearly ROI…
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.